Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    NEJM Interview: Dan Liljenquist on generic-drug market failures and the creation of a nonprofit drug manufacturer.

    NEJM Interview: Dan Liljenquist on generic-drug market failures and the creation of a nonprofit drug manufacturer.

    FromNEJM Interviews

    Start listeningView podcast show

    NEJM Interview: Dan Liljenquist on generic-drug market failures and the creation of a nonprofit drug manufacturer.

    FromNEJM Interviews

    ratings:
    Length:
    12 minutes
    Released:
    May 16, 2018
    Format:
    Podcast episode

    Description

    Dan Liljenquist is a vice president at Intermountain Healthcare. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. D. Liljenquist, G. Bai, and G.F. Anderson. Addressing Generic-Drug Market Failures - The Case for Establishing a Nonprofit Manufacturer. N Engl J Med 2018;378:1857-9.
    Released:
    May 16, 2018
    Format:
    Podcast episode

    Titles in the series (100)

    The New England Journal of Medicine (NEJM) Audio interview RSS feed. NEJM (http://www.nejm.org) is a weekly general medical journal that publishes new medical research findings, review articles, and editorial opinion on a wide variety of topics of importance to biomedical science and clinical practice.